Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
MOTS-c and BAC Water Mix

MOTS-c Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example MOTS-c Titration Schedule

ItemDetails
Community dose1–5 mg SC 2–3× per week
Cycles4–12 weeks + 4–8 off
Phase 2a trialOnce-daily SC ×12 weeks (active)

Community protocols disagree with each other (500 mcg–5 mg; daily to weekly) — the range reflects that disagreement. A Phase 2a trial (NCT07505745, n=120, prediabetes) began in February 2026, the first registered human efficacy study; the analog CB4211 completed Phase 1 safely. WADA-banned since 2024.

Possible vial strengths:

What Is It?

MOTS-c

Mitochondrial-derived peptide studied in metabolic research.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix MOTS-c

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

MOTS-c Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

MOTS-c is a 16-amino-acid peptide unusually encoded inside mitochondrial DNA rather than the cell nucleus, making it one of a small family called mitochondrial-derived peptides alongside humanin. Your own body produces more of it during exercise, and it acts on the AMPK energy-sensing pathway, which is why researchers describe it as an "exercise mimetic." That endogenous origin is real science; it does not mean the injectable products sold online are the same as what your cells make.
No — as of 2026, MOTS-c is not FDA-approved for any condition and is not legally marketed for human therapeutic use; products sold as "research use only" are exactly that. The FDA's compounding advisory committee is reviewing MOTS-c and several other peptides in 2026 to decide whether licensed compounding pharmacies may prepare them, but that review is not the same as approval. Anti-doping agencies also treat it as a prohibited experimental substance in sport.
Most of the compelling evidence is from mice and cell studies, where MOTS-c improved glucose tolerance, limited weight gain on high-fat diets, and boosted exercise capacity. Human data is still very limited — there are no completed large randomized efficacy trials in the published literature — so the honest position is "biologically promising, clinically unproven." Impressive rodent metabolism results do not reliably translate to safe or effective human outcomes, which is a recurring pattern in this field.
This is unsettled research territory, not a settled answer in either direction. Because MOTS-c influences core energy and stress pathways that are also relevant to how cells grow, scientists are studying its role in cancer biology, but there is no human evidence establishing it as either a treatment or a proven risk. That uncertainty is itself the point: it isn't something to self-manage, and anyone with a cancer history or concern should raise it with an oncologist rather than an online protocol.
There is no established human safety profile, no official dosing guideline, and no long-term data — meaning anyone self-injecting is effectively running an uncontrolled experiment on themselves. On top of that, "research use only" products aren't manufactured or tested to human-injectable standards for purity, dose accuracy, or sterility, so contamination and mislabeled potency are real risks independent of the molecule itself. If you're interested in MOTS-c's metabolic goals, a licensed clinician can discuss evidence-based, approved options instead.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides